On Aug 12, 2026, DRCT reported earnings of -4.73 USD per share (EPS) for Q2 26, beating the estimate of -9.79 USD, resulting in a 51.72% surprise. Revenue reached 7.83 million, compared to an expected 9.01 million, with a -13.10% difference. The market reacted with a -0.72% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -9.20 USD, with revenue projected to reach 9.43 million USD, implying an increase of 94.50% EPS, and increase of 20.46% in Revenue from the last quarter.